Unknown OBSERVATIONAL NCT02496572

Effectiveness of a Simplified Short Regimen for Multidrug Resistant Tuberculosis in Uzbekistan

Effectiveness of a Simplified Short Regimen for Multidrug Resistant Tuberculosis Treatment in Karakalpakstan, Uzbekistan

Sponsor: Imperial College London

Conditions Multidrug Resistant Tuberculosis

Interventions Short course MDR-TB treatment regimen

Updated 7 times since 2017 Last updated: Jul 9, 2015 Started: Sep 30, 2013 Primary completion: Mar 31, 2016 Completion: Apr 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02496572, this observational or N/A phase trial focuses on Multidrug Resistant Tuberculosis and remains ongoing. Sponsored by Imperial College London, it has been updated 7 times since 2013, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Jun 2018 — Jan 2021 [monthly]

Unknown Status
Apr 2018 — Jun 2018 [monthly]

Unknown Status

Phase: PHASE3 → None

▶ Show 2 earlier versions

Aug 2017 — Apr 2018 [monthly]

Unknown Status PHASE3

Status: Active Not Recruiting → Unknown Status
Jan 2017 — Aug 2017 [monthly]

Active Not Recruiting PHASE3

First recorded

Sep 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Imperial College London
Medecins Sans Frontieres, Netherlands
Ministry of Health, Republic of Uzbekistan

Data source: Medecins Sans Frontieres, Netherlands

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nukus, Uzbekistan